IL252197A0 - A method for treating, preventing or reducing the risk of skin infection - Google Patents

A method for treating, preventing or reducing the risk of skin infection

Info

Publication number
IL252197A0
IL252197A0 IL252197A IL25219717A IL252197A0 IL 252197 A0 IL252197 A0 IL 252197A0 IL 252197 A IL252197 A IL 252197A IL 25219717 A IL25219717 A IL 25219717A IL 252197 A0 IL252197 A0 IL 252197A0
Authority
IL
Israel
Prior art keywords
risk
treating
preventing
reducing
skin infection
Prior art date
Application number
IL252197A
Other languages
English (en)
Hebrew (he)
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of IL252197A0 publication Critical patent/IL252197A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
IL252197A 2014-11-14 2017-05-10 A method for treating, preventing or reducing the risk of skin infection IL252197A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462080212P 2014-11-14 2014-11-14
PCT/US2015/060851 WO2016077818A1 (en) 2014-11-14 2015-11-16 Method for treating, preventing, or reducing the risk of skin infection

Publications (1)

Publication Number Publication Date
IL252197A0 true IL252197A0 (en) 2017-07-31

Family

ID=55955188

Family Applications (1)

Application Number Title Priority Date Filing Date
IL252197A IL252197A0 (en) 2014-11-14 2017-05-10 A method for treating, preventing or reducing the risk of skin infection

Country Status (21)

Country Link
US (1) US10471046B2 (OSRAM)
EP (1) EP3217974A4 (OSRAM)
JP (1) JP2017534654A (OSRAM)
KR (1) KR20170084200A (OSRAM)
CN (1) CN107205989A (OSRAM)
AR (1) AR102666A1 (OSRAM)
AU (1) AU2015346023A1 (OSRAM)
BR (1) BR112017009989A2 (OSRAM)
CA (1) CA2967825A1 (OSRAM)
CL (1) CL2017001245A1 (OSRAM)
CR (1) CR20170196A (OSRAM)
EA (1) EA201791051A1 (OSRAM)
HK (1) HK1244211A1 (OSRAM)
IL (1) IL252197A0 (OSRAM)
MX (1) MX389005B (OSRAM)
NI (1) NI201700057A (OSRAM)
PH (1) PH12017500887A1 (OSRAM)
SG (1) SG11201703856VA (OSRAM)
SV (1) SV2017005444A (OSRAM)
UY (1) UY36402A (OSRAM)
WO (1) WO2016077818A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180011843A (ko) 2015-06-11 2018-02-02 바실리어 파마슈티카 인터내셔널 리미티드 유출-펌프 억제제 및 이의 치료적 용도
CA3045954A1 (en) * 2016-12-09 2018-06-14 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase
CN107721943A (zh) * 2017-10-26 2018-02-23 沈阳药科大学 含联芳基腙结构的噁唑烷酮类化合物及其制备方法
KR20190130243A (ko) 2018-05-14 2019-11-22 (주)텔리언 트러스트 인덱스를 이용한 공유경제 시스템 및 방법
CA3145394C (en) 2019-06-25 2024-01-09 Amtixbio Co., Ltd. A novel aminoalkanoic acid derivative containing a biphenyl group and an antifungal pharmaceutical composition comprising the same
CN115677679A (zh) * 2021-07-26 2023-02-03 沈阳药科大学 含联芳基腙结构的噁唑烷酮化合物及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES332272A1 (es) 1965-10-20 1967-11-16 Milwaukee Chaplet & Mfg Company Inc Un dispositivo regulador de programa.
GB1185685A (en) 1966-01-11 1970-03-25 Quinoderm Ltd Method of Making Pharmaceutical Compositions
US3418055A (en) 1967-04-03 1968-12-24 Schwartzman Gilbert Pressure operated applicator and cap construction
US3410645A (en) 1967-05-08 1968-11-12 Schwartzman Gilbert Concave diaphragm applicator
US3535422A (en) 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US3669323A (en) 1969-12-12 1972-06-13 American Can Co One-way valve insert for collapsible dispensing containers
US4056611A (en) 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4620648A (en) 1982-07-06 1986-11-04 Dab-O-Matic Corp. Pressure-responsive valve
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4693623A (en) 1984-03-02 1987-09-15 Dab-O-Matic Corp. Pressure-responsive valve for an applicator
US4937370A (en) 1987-06-02 1990-06-26 The Procter & Gamble Company Novel chromophores, sunscreen compositions and methods for preventing sunburn
US4999186A (en) 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US4800197A (en) 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US4891228A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891227A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5087445A (en) 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
CA2119556C (en) 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
AU5375896A (en) 1995-03-27 1996-10-16 Isis Pharmaceuticals, Inc. Nitrogenous macrocyclic compounds
PT952151E (pt) 1995-09-22 2003-10-31 Wakunaga Pharma Co Ltd Intermediarios para utilizacao na preparacao de novos derivados de acido piridonacarboxilico ou seus sais
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CN1433413A (zh) 2000-06-05 2003-07-30 东亚制药株式会社 新的噁唑烷酮衍生物及其制备方法
US20130059774A1 (en) * 2000-08-01 2013-03-07 Mahesh Vithalbhai Patel Efflux pump inhibitors
WO2003030906A1 (en) 2001-10-11 2003-04-17 Pharmacia & Upjohn Company Treating infections by administration of oxazolidinones to the skin
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
MXPA05009430A (es) 2003-03-05 2006-04-07 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para hacer y usar a los mismos.
CN100457742C (zh) 2003-06-03 2009-02-04 瑞伯-X医药品有限公司 联芳基杂环化合物的制备和用途
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
WO2005012271A2 (en) 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US20070197541A1 (en) 2003-07-29 2007-08-23 Oyelere Adegboyega K Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
EP1778653A1 (en) 2004-07-28 2007-05-02 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
MX2007001134A (es) 2004-07-30 2007-04-17 Abbott Lab Preparacion de antibacterianos de acido piridonacarboxilico.
ES2901955T3 (es) 2004-10-08 2022-03-24 Abbvie Inc Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
DK1868581T3 (da) 2005-04-11 2012-07-09 Abbott Lab Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler
WO2006133397A2 (en) 2005-06-08 2006-12-14 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
HRP20171285T1 (hr) 2005-08-24 2017-10-20 Melinta Therapeutics, Inc. Spojevi triazola i postupci dobivanja i njihova upotreba
WO2011139832A2 (en) * 2010-04-28 2011-11-10 Rib-X Pharmaceuticals, Inc. Method for treating mycobacterial infections

Also Published As

Publication number Publication date
MX389005B (es) 2025-03-20
EP3217974A4 (en) 2018-07-25
JP2017534654A (ja) 2017-11-24
US10471046B2 (en) 2019-11-12
WO2016077818A1 (en) 2016-05-19
CR20170196A (es) 2017-07-10
CL2017001245A1 (es) 2018-02-09
SG11201703856VA (en) 2017-06-29
EP3217974A1 (en) 2017-09-20
EA201791051A1 (ru) 2018-01-31
AR102666A1 (es) 2017-03-15
PH12017500887A1 (en) 2017-11-06
CN107205989A (zh) 2017-09-26
CA2967825A1 (en) 2016-05-19
US20160136137A1 (en) 2016-05-19
MX2017006319A (es) 2017-08-10
NI201700057A (es) 2017-09-04
AU2015346023A1 (en) 2017-06-01
KR20170084200A (ko) 2017-07-19
UY36402A (es) 2016-06-30
SV2017005444A (es) 2017-08-31
BR112017009989A2 (pt) 2018-01-02
HK1244211A1 (zh) 2018-08-03

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
IL256501B (en) Causes, uses and methods of treating synuclein pathology
PL3286311T3 (pl) Sposób leczenia nowotworów złośliwych
EP3151797A4 (en) Methods and devices for treating the skin
IL254596B (en) A method for operating a reverse osmosis membrane treatment system and a reverse osmosis membrane treatment system
EP3107642A4 (en) Systems and methods for treating blood
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
EP3242947A4 (en) Method for the treatment of malignancies
SG10201913559VA (en) Methods for treating and preventing c. difficile infection
PL3215219T3 (pl) System do zabiegów na skórze
GB2567616B (en) Treatment method
IL252197A0 (en) A method for treating, preventing or reducing the risk of skin infection
PL3183003T3 (pl) SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA
SG11202001806TA (en) Treatment method
GB2571601B (en) Treatment method
EP3159116A4 (en) Medical treatment system setting method
GB201402909D0 (en) Treating infection
IL255012A0 (en) Preparations and methods for treating skin conditions
HUE052429T2 (hu) Összeállítás sebészeti kezeléshez
EP3269369A4 (en) Respiratory infection treating agent
SG11201706885RA (en) Novel treatment method
EP3271017A4 (en) Treatment of skin conditions
GB2531418B (en) Treatment system for treating hyperhidrosis
HK1258790A1 (en) Methods for treating cardiac injury
HK1234660A1 (en) Method of treating skin conditions